dobutamine has been researched along with enalaprilat anhydrous in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schaaf, LJ; Tremel, LC; Vernon, KK; Wulf, BG | 1 |
| Charocopos, F; Gavras, H | 1 |
| Gheorghiade, M; Goldstein, S; Kono, T; Levine, TB; Sabbah, HN | 1 |
| Fetics, B; Hare, JM; Kass, DA; Maughan, WL; Pak, PH; Wittstein, IS | 1 |
| Gattis, WA; Gheorghiade, M; Jain, P; Klein, L; Massie, BM | 1 |
2 review(s) available for dobutamine and enalaprilat anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
Topics: Aged; Diuretics; Dobutamine; Enalaprilat; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Hydrazones; Injections, Intravenous; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Pulmonary Wedge Pressure; Pyridazines; Renal Agents; Simendan; Vasodilator Agents | 2003 |
6 other study(ies) available for dobutamine and enalaprilat anhydrous
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
Topics: Critical Care; Dobutamine; Dopamine; Drug Combinations; Drug Incompatibility; Enalaprilat; Heparin; Hydrogen-Ion Concentration; Infusions, Intravenous; Nitroglycerin; Nitroprusside; Potassium Chloride | 1990 |
Cardiovascular effects of dobutamine and converting enzyme inhibition in rats with diabetic ketoacidosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output; Catecholamines; Coronary Circulation; Diabetic Ketoacidosis; Dipeptides; Dobutamine; Enalaprilat; Heart Rate; Hemodynamics; Male; Rats; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance | 1985 |
Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
Topics: Animals; Blood Pressure; Cardiac Output; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Enalaprilat; Heart Failure; Heart Rate; Hemodynamics; Nitroprusside; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1993 |
Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Dilated; Compliance; Depression, Chemical; Diastole; Dobutamine; Enalaprilat; Enzyme Inhibitors; Female; Heart; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Ventricular Dysfunction, Left | 2001 |